Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
28.00
+0.10 (0.36%)
Aug 12, 2026, 4:00 PM EDT - Market closed
KMTS Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Cash & Equivalents | 99.71 | 237.6 | 8.25 | 24.34 | 5.76 |
Short-Term Investments | 96.72 | - | - | - | - |
Cash & Short-Term Investments | 196.43 | 237.6 | 8.25 | 24.34 | 5.76 |
Cash Growth | -17.32% | 2780.29% | -66.11% | 322.90% | - |
Accounts Receivable | 14.54 | 8.08 | 2 | - | - |
Inventory | 6.71 | 6.57 | 3.29 | - | - |
Other Current Assets | 4.68 | 3.08 | 1.37 | 1.85 | 0.41 |
Total Current Assets | 222.36 | 255.33 | 14.91 | 26.2 | 6.17 |
Net Property, Plant & Equipment | 62.45 | 36.91 | 28.39 | 3.08 | 1.13 |
Long-Term Investments | 65.77 | - | - | - | - |
Other Long-Term Assets | 7.89 | 3.51 | 2.65 | 1.24 | 0.58 |
Total Assets | 358.47 | 295.74 | 45.95 | 30.52 | 7.87 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Accounts Payable | 27.3 | 23.96 | 23.89 | 1.7 | 1.83 |
Accrued Expenses | 23.05 | 13.83 | 9.08 | 3.85 | 1.73 |
Current Portion of Leases | 0.03 | 0.19 | - | 1.06 | 0.45 |
Total Current Liabilities | 50.37 | 37.98 | 32.97 | 6.61 | 4.02 |
Long-Term Debt | 42.65 | 41.1 | 42.54 | 20.24 | - |
Long-Term Leases | 4.11 | 3.03 | 2.63 | 1.55 | - |
Other Long-Term Liabilities | 1.68 | 8.24 | 0.08 | 0.36 | - |
Total Long-Term Liabilities | 48.44 | 52.36 | 45.25 | 22.15 | - |
Total Liabilities | 98.81 | 90.34 | 78.22 | 28.76 | 4.02 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Common Stock | 58.38 | 51.35 | 19.91 | 0 | 0 |
Additional Paid-in Capital | 853.35 | 674.31 | 177.15 | 171.85 | 139.84 |
Accumulated Other Comprehensive Income | -0.22 | - | - | - | - |
Retained Earnings | -651.86 | -520.25 | -406.44 | -170.08 | -135.98 |
Total Common Shareholders' Equity | 259.66 | 205.41 | -209.38 | 1.77 | 3.86 |
Minority Interest | - | - | 177.11 | - | - |
Shareholders' Equity | 259.66 | 205.41 | 177.11 | 1.77 | 3.86 |
Total Liabilities & Equity | 358.47 | 295.74 | 45.95 | 30.52 | 7.87 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Total Debt | 46.79 | 44.31 | 45.17 | 22.85 | 0.45 |
Net Cash (Debt) | 149.64 | 193.28 | -36.92 | 1.49 | 5.3 |
Net Cash Growth | -22.58% | - | - | -71.85% | - |
Net Cash Per Share | 2.76 | 7.86 | -1.86 | - | - |
Book Value | 259.66 | 205.41 | -209.38 | 1.77 | 3.86 |
Book Value Per Share | 4.79 | 8.36 | -10.53 | - | - |
Tangible Book Value | 259.66 | 205.41 | -209.38 | 1.77 | 3.86 |
Tangible Book Value Per Share | 4.79 | 8.36 | -10.53 | - | - |